Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Cancer Immunology Research
|
February 19, 2022
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses
Andrew Fedoriw, Leilei Shi, Shane O'Brien, et al.
Cancer Cell
|
July 2, 2019
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw, Satyajit R Rajapurkar, Shane O'Brien, et al.
Plos One
|
October 11, 2011
Defining natural history: assessment of the ability of college students to aid in characterizing clinical progression of Niemann-Pick disease, type C
Jenny Shin, Katrina Epperson, Nicole M Yanjanin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Cancer Immunology Research
|
February 19, 2022
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses
Andrew Fedoriw, Leilei Shi, Shane O'Brien, et al.
Cancer Cell
|
July 2, 2019
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw, Satyajit R Rajapurkar, Shane O'Brien, et al.
Plos One
|
October 11, 2011
Defining natural history: assessment of the ability of college students to aid in characterizing clinical progression of Niemann-Pick disease, type C
Jenny Shin, Katrina Epperson, Nicole M Yanjanin, et al.
Page
of 2